Pharma-Bio Serv, Inc. PBSV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.00% | 11.83% | -7.13% | -7.87% | -18.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.00% | 11.83% | -7.13% | -7.87% | -18.82% |
| Cost of Revenue | 18.40% | 12.68% | -7.67% | -12.82% | -22.10% |
| Gross Profit | 20.44% | 10.17% | -5.95% | 3.07% | -9.62% |
| SG&A Expenses | -14.03% | -17.40% | -5.04% | 0.17% | -12.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.75% | 1.71% | -6.79% | -8.22% | -18.68% |
| Operating Income | 77.13% | 247.20% | -2.49% | 13.50% | 17.78% |
| Income Before Tax | 94.69% | 137.26% | 276.29% | 129.05% | 27.98% |
| Income Tax Expenses | 164.58% | 16.36% | 227.27% | 114.19% | -125.26% |
| Earnings from Continuing Operations | 93.05% | 144.23% | 287.06% | -100.62% | 33.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 93.05% | 144.23% | 287.06% | -100.62% | 33.93% |
| EBIT | 77.13% | 247.20% | -2.49% | 13.50% | 17.78% |
| EBITDA | 80.51% | 299.12% | 3.74% | 20.72% | 20.97% |
| EPS Basic | 93.26% | 142.86% | 250.00% | -100.00% | 34.07% |
| Normalized Basic EPS | 94.74% | 140.74% | 233.33% | 125.00% | 27.85% |
| EPS Diluted | 88.89% | 150.00% | 150.00% | -100.00% | 35.71% |
| Normalized Diluted EPS | 94.74% | 140.74% | 233.33% | 125.00% | 27.85% |
| Average Basic Shares Outstanding | -0.11% | -0.14% | -0.23% | -0.11% | -0.15% |
| Average Diluted Shares Outstanding | -0.12% | -0.14% | -0.21% | -0.11% | -0.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -0.59% | -- | -- | -- |